✈️ The CellCarta Team is heading to Boston for World CB & CDx! We excited to hear about your latest projects, including companion diagnostics in China.  Don't miss out! Book a meeting with a team member today: buff.ly/CW9YVen

At CellCarta, we know that there’s still work to do. We are grateful for the patients, advocates, clinicians and scientists around the world dedicated to understanding disease and developing more effective diagnostics and treatments for patients. #WorldCancerResearchDay

Join us at Biomarkers and Precision Medicine to hear about our collaborative work with Tivenix. This work focuses on a novel, AI-based diagnostic for Alzheimer's disease. Don’t miss the discussion on advancing precision medicine with innovative biomarker strategies!

👋The team is at Biomarkers and Precision Medicine! Make sure to drop by Booth #48 to see how we can help you tackle your biggest biomarker research challenges. Stop by for a chat and discover how we can accelerate your research, or book a meeting👉 buff.ly/KsClqIy

🏷️Streamline sample management with our customizable labeling solutions to meet the demands of clinical research: - Layout and data customized for your study - Multi-color, tear proof - Smudge-proof printing - Adhesive tested to -196ºC Learn more! buff.ly/4b8YSi8

🎯ADCs are a class of targeted cytotoxic therapies that are changing the landscape of cancer treatment. ADC pioneer Dr. Thomas Powles joined us to discuss the challenges and future directions of development. Ready for expert insights? Watch our webcast! buff.ly/RosGi16

Comprehensive molecular profiling is key to advancing precision oncology. With the TSO500 assay, you gain broad genomic insights, supporting improved patient stratification, biomarker discovery, and greater trial efficiency. Read our article to learn more! buff.ly/7lfWljO

Exciting news! Our Leica tissue processor is ready to streamline histopathology workflows. What does that mean for you? Faster turnaround times, with rapid tissue processing of up to 400 cassettes at once. Contact our team to learn more! buff.ly/01jnG5F

👋Biomarkers and precision medicine US is coming up, and we're excited to see you in San Francisco! 📍Visit us at Booth #8 🧬🔬Our team is ready to discuss how multi-omic biomarker strategies can accelerate your precision medicine programs. Make sure to say hi!

🤝Excited to connect at SITC 2025! We'll be at Booth #527. We are proud to partner with cancer immunotherapy innovators at every stage, from biomarker discovery to late-phase clinical trials. Visit us to learn how our expertise can support your program goals! #SITC2025

🎯CellCarta is the first CRO to offer oncoReveal™ CDx pan-cancer solid tumor IVD for patient management. Learn how we can support your trial: buff.ly/hxcawFV *Visit Pillar Biosciences website for details on regulatory approval: buff.ly/GNoAboq

The AMERICAN College of Rheumatology meeting kicks off this week, and we are heading to Chicago! If you’re advancing your biomarker strategy or need support for your clinical projects, book a meeting or say hi to Simone on the conference floor! buff.ly/NJOo6Ox #ACR25

Biomarkers and Precision Medicine US kicks off NEXT WEEK! 🌉 Jill Whitham and Neil O'Kane will be at booth #8, ready to discuss your wins and challenges in your biomarker strategy. Make sure to stop by! Busy schedule? Book a meeting with the team: buff.ly/04z3y1L

🧬Did we miss you at #ESMO2025? Our poster shared validation data for the Biofidelity Aspyre assay, which we elevated to patient management standards for simplified mutational profiling in NSCLC. Get the full validation report here!👉 buff.ly/lWPb2aS

Our famous "falling blocks" game is on the road with us at #SITC2025 this year! Stop by Booth 527 to see if you can make it onto the leaderboard! James and our team are happy to share tips on strategy when it comes to both biomarkers and gaming 🎮 📅buff.ly/IpW5knK

We're looking forward to sharing some of our latest work at the upcoming Society for Immunotherapy of Cancer Annual Meeting. 📍Visit us at Booth 527 to talk to our experts, ask questions, and see how we can support your immunotherapy projects. 📅buff.ly/IpW5knK

Are HGRAC applications hindering your clinical trials in China? Our blog post helps you through the process & highlights how working with the right partner can make it simpler. Sidestep HGRAC roadblocks: cellcarta.com/science-hub/hg… #ClinicalTrials #PrecisionMedicine

From all of us at CellCarta, we wish you a joyful holiday season filled with relaxation. Thank you for your continued partnership in advancing biomarker strategy and therapeutic development. We look forward to achieving new milestones together in the coming year!

Happy New Year! As we reflect on 2025 and look forward to 2026, we wish you all a year of impact, innovation, and meaningful progress in precision medicine. #CellCarta #PrecisionMedicine

Interested in detecting specific mutations in disease-related pathways? CellCarta offers a range of genomic assays from single genes to multi-mutation panels. See which mutations our panels detect in EGFR, KRAS, BRAF, FGFR and PI3KCA 👉buff.ly/M6Invio